Corrigendum: Characterization of Two Novel Bacteriophages Infecting Multidrug-Resistant (MDR) Acinetobacter baumannii and Evaluation of Their Therapeutic Efficacy in vivo (Front. Microbiol., (2018), 9, (696), 10.3389/fmicb.2018.00696);Characterization of two novel bacteriophages infecting multidrug-resistant (MDR) Acinetobacter baumannii and evaluation of their therapeutic efficacy in vivo

Frontiers in Microbiology

Volumn 9, Issue APR, 2018, Pages

  Cha, Kyoungeun ^a   Oh, Hynu K ^a   Jang, Jae Y ^a   Jo, Yunyeol ^a   Kim, Won K ^a   Ha, Geon U ^a   Ko, Kwan S ^b   Myung, Heejoon ^a  

^a Hankuk University of Foreign Studies   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Acinetobacter baumannii; Bacteriophage therapy; Genome analysis; Mouse model; Multidrug resistance; genome analysis; bacteriophage therapy; mouse model; multidrug resistance

Indexed keywords

CYCLOPHOSPHAMIDE; HISTAMINE; IMMUNOGLOBULIN E;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIOPHAGE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE REARRANGEMENT; MOLECULAR GENETICS; MOUSE; MULTIDRUG RESISTANCE; NEXT GENERATION SEQUENCING; NONHUMAN; PH; TRANSMISSION ELECTRON MICROSCOPY; WHOLE GENOME SEQUENCING;

EID: 85045262622     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2021.815173     Document Type: Erratum

References (42)

1. Abedon, S. T. (2017). Bacteriophage clinical use as antibacterial "drugs": utility and precedent. Microbiol. Spectr. 5:BAD-0003-2016. doi: 10.1128/microbiolspec. BAD-0003-2016
2. Bailey, N. T. J. (1959). Statistical Methods in Biology. London: The English Universities Press Ltd
3. Bartual, S. G., Seifert, H., Hippler, C., Luzon, M. A., Wisplinghoff, H., and Rodríguez-Valera, F. (2005). Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43, 4382-4390. doi: 10.1128/JCM.43.9.4382-4390.2005
4. Botstein, D. (1980). A theory of modular evolution for bacteriophages. Ann. N.Y. Acad. Sci. 354, 484-490
5. Clokie, M. R. J., Kropinski, A. M., and Lavigne, R. (2018). "Bacteriophages methods and protocols," in Methods in Molecular Biology, Vol. 3 (New York, NY: Springer Nature)
6. Clokie, M. R. J., and Kropinski, A. M. (2009a). "Bacteriophages methods and protocols," in Methods in Molecular Biology, Vol. 1 (New York, NY: Springer Nature)
7. Clokie, M. R. J., and Kropinski, A. M. (2009b). "Bacteriophages methods and protocols," in Methods in Molecular Biology, Vol. 2 (New York, NY: Springer Nature)
8. Davies, R. L., and Lee, I. (2006). Diversity of temperate bacteriophages induced in bovine and ovine Mannheimia haemolytica isolates and identification of a new P2-like phage. FEMS Microbiol. Lett. 260, 162-170. doi: 10.1111/j.1574-6968.2006.00314.x
9. Dijkshoorn, L., Nemec, A., and Seifert, H. (2007). An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5, 939-951. doi: 10.1038/nrmicro1789
10. Doi, Y., Murray, G. L., and Peleg, A. Y. (2015). Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options. Semin. Respir. Crit. Care Med. 36, 85-98. doi: 10.1055/s-0034-1398388
11. García-Quintanilla, M., Pulido, M. R., López-Rojas, R., Pachón, J., and McConnell, M. J. (2013). Emerging therapies for multidrug resistant Acinetobacter baumannii. Trends Microbiol. 21, 157-163. doi: 10.1016/j.tim.2012.12.002
12. Hua, Y., Luo, T., Yang, Y., Dong, D., Wang, R., Wang, Y., et al. (2018). Phage therapy as a promising new treatment for lung infection caused by carbapenem-resistant Acinetobacter baumannii in mice. Front. Microbiol. 8:2659. doi: 10.3389/fmicb.2017.02659
13. Huang, T. W., Lauderdale, T. L., Liao, T. L., Hsu, M. C., Chang, F. Y., Chang, S. C., et al. (2015). Effective transfer of a 47 kb NDM-1-positive plasmid among Acinetobacter species. J. Antimicrob. Chemother. 70, 2734-2738. doi: 10.1093/jac/dkv191
14. Huys, I., Pirnay, J.-P., Lavigne, R., Jennes, S., De Vos, D., Casteels, M., et al. (2013). Paving a regulatory pathway for phage therapy. EMBO Rep. 14, 951-954. doi: 10.1038/embor.2013.163
15. Hyman, P., and Abedon, S. T. (2009). Practical methods for determining phage growth parameters. Methods Mol. Biol. 501, 175-202. doi: 10.1007/978-1-60327-164-6_18
16. Jeon, J., D'Souza, R., Pinto, N., Ryu, C. M., Park, J., Yong, D., et al. (2016a). Characterization and complete genome sequence analysis of two myoviral bacteriophages infecting clinical carbapenem-resistant Acinetobacter baumannii isolates. J. Appl. Microbiol. 121, 68-77. doi: 10.1111/jam.13134
17. Jeon, J., Ryu, C. M., Lee, J. Y., Park, J. H., Yong, D., and Lee, K. (2016b). In vivo application of bacteriophage as a potential therapeutic agent to control OXA-66-Like carbapenemase-producing Acinetobacter baumannii strains belonging to sequence ype 357. Appl. Environ. Microbiol. 82, 4200-4208. doi: 10.1128/AEM.00526-16
18. Keller, B., Dubochet, J., Adrien, M., Maeder, M., Wurtz, M., and Kellenberger, E. (1988). Length and shape varients of bacteriophage T4 head: mutations I scaffolding core genes 68 and 22. J. Virol. 62, 2960-2969
19. Kim, M. S., Hong, S. S., Park, K., and Myung, H. (2013). Genomic analysis of bacteriophage PBECO4 infecting Escherichia coli O157:H7. Arch. Virol. 158, 2399-2403. doi: 10.1007/s00705-013-1718-3
20. Krahn, T., Wibberg, D., Maus, I., Winkler, A., Bontron, S., Sczyrba, A., et al. (2016). Intraspecies transfer of the chromosomal Acinetobacter baumannii blaNDM-1 carbapenemase gene. Antimicrob Agents Chemother. 60, 3032-3040. doi: 10.1128/AAC.00124-16
21. Kröger, C., Kary, S. C., Schauer, K., and Cameron, A. D. (2017). Genetic regulation of virulence and antibiotic resistance in Acinetobacter baumannii. Genes 8:12. doi: 10.3390/genes8010012
22. Kropinski, A. M., Mazzocco, A., Waddell, T. E., Lingohr, E., and Johnson, R. P. (2009). Enumeration of bacteriophages by double agar overlay plaque assay. Methods Mol. Biol. 501, 69-76. doi: 10.1007/978-1-60327-164-6_7
23. Kusradze, I., Karumidze, N., Rigvava, S., Dvalidze, T., Katsitadze, M., Amiranashvili, I., et al. (2016). Characterization and testing the efficiency of Acinetobacter baumannii phage vB-GEC_Ab-M-G7 as an antibacterial agent. Front Microbiol. 7:1590. doi: 10.3389/fmicb.2016.01590
24. Lee, C.-R., Lee, J. H., Park, M., Park, K. S., Bae, I. K., Kim, Y. B., et al. (2017). Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front. Cell. Infect. Microbiol. 7:55. doi: 10.3389/fcimb.2017.00055
25. Li, E., Zhao, J., Ma, Y., Wei, X., Li, H., Lin, W., et al. (2016). Characterization of a novel Achromobacter xylosoxidans specific siphoviruse: phiAxp-1. Sci. Rep. 6:21943. doi: 10.1038/srep21943
26. Lin, D. M., Koskella, B., and Lin, H. C. (2017). Phage therapy: an alternative to antibiotics in the age of multi-drug resistance. World J. Gastrointest. Pharmacol. Ther. 8, 162-173. doi: 10.4292/wjgpt.v8.i3.162
27. McConnell, M. J., Actis, L., and Pachon, J. (2013). Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol. Rev. 37, 130-155. doi: 10.1111/j.1574-6976.2012.00344.x
28. Merabishvili, M., Vandenheuvel, D., Kropinski, A. M., Mast, J., De Vos, D., Verbeken, G., et al. (2014). Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii. PLoS ONE 9:e104853. doi: 10.1371/journal.pone.0104853
29. Mihu, M. R., and Martinez, L. R. (2011). Novel therapies for treatment of multi-drug resistant Acinetobacter baumannii skin infections. Virulence 2, 97-102 doi: 10.4161/viru.2.2.15061
30. Parasion, S., Kwiatek, M., Gryko, R., Mizak, L., and Malm, A. (2014). Bacteriophages as an alternative strategy for fighting biofilm development. Pol. J. Microbiol. 63, 137-145
31. Park, K., Cha, K. E., and Myung, H. (2014). Observation of inflammatory responses in mice orally fed with bacteriophage T7. J. Appl. Microbiol. 117, 627-633. doi: 10.1111/jam.12565
32. Regeimbal, J. M., Jacobs, A. C., Corey, B. W., Henry, M. S., Thompson, M. G., Pavlicek, R. L., et al. (2016). Personalized therapeutic cocktail of wild environmental phages rescues mice from Acinetobacter baumannii wound infections. Antimicrob. Agents Chemother. 60, 5806-5816. doi: 10.1128/AAC.02877-15
33. Sambrook, J., and Russell, D. W. (2006). Purification of bacteriophage ? particles by centrifugation through a glycerol step gradient. Cold Spring Harb. Protoc. 2006:pdb.prot3969. doi: 10.1101/pdb.prot3969
34. Schooley, R. T., Biswas, B., Gill, J. J., Hernandez-Morales, A., Lancaster, J., Lessor, L., et al. (2017). Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob. Agents Chemother. 61:e00954-17. doi: 10.1128/AAC.00954-17
35. Shivaswamy, V. C., Kalasuramath, S. B., Sadanand, C. K., Basavaraju, A. K., Ginnavaram, V., Bille, S., et al. (2015). Ability of bacteriophage in resolving wound infection caused by multidrug-resistant Acinetobacter baumannii in uncontrolled diabetic rats. Microb. Drug Resist. 21, 171-177. doi: 10.1089/mdr.2014.0120
36. Tuon, F. F., Rocha, J. L., and Merlini, A. B. (2015). Combined therapy for multi-drug-resistant Acinetobacter baumannii infection-is there evidence outside the laboratory? J. Med. Microbiol. 64, 951-959. doi: 10.1099/jmm.0.000144
37. Turner, D., Wand, M. E., Briers, Y., Lavigne, R., Sutton, J. M., and Reynolds, D. M. (2017). Characterisation and genome sequence of the lytic Acinetobacter baumannii bacteriophage vB_AbaS_Loki. PLoS ONE 12:e0172303. doi: 10.1371/journal.pone.0172303
38. Wang, Y., Mi, Z., Niu, W., An, X., Yuan, X., Liu, H., et al. (2016). Intranasal treatment with bacteriophage rescues mice from Acinetobacter baumannii-mediated pneumonia. Fut. Microbiol. 11, 631-641. doi: 10.2217/fmb.16.11
39. Weber, B. S., Harding, C. M., and Feldman, M. F. (2016). Pathogenic Acinetobacter: from the cell surface to infinity and beyond. J. Bacteriol. 198, 880-887. doi: 10.1128/JB.00906-15
40. Yang, H., Liang, L., Lin, S., and Jia, S. (2010). Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii. BMC Microbiol. 10:131. doi: 10.1186/1471-2180-10-131
41. Zhang, G., Leclercq, S. O., Tian, J., Wang, C., Yahara, K., Ai, G., et al. (2017). A new subclass of intrinsic aminoglycoside nucleotidyltransferases, ANT(3")-II, is horizontally transferred among Acinetobacter spp. by homologous recombination. PLoS Genet. 13:e1006602. doi: 10.1371/journal.pgen.1006602
42. Zhang, J., Liu, X., Li, and Li, X. J. (2015). Bioinformatic analysis of phage AB3, a phiKMV-like virus infecting Acinetobacter baumannii. Genet. Mol. Res. 14, 190-198. doi: 10.4238/2015